DOI QR코드

DOI QR Code

Retiform hemangioendothelioma in the infratemporal fossa and buccal area: a case report and literature review

  • Kim, Il-Kyu (Division of Oral and Maxillofacial Surgery, Department of Dentistry, Inha University School of Medicine) ;
  • Cho, Hyun-Young (Division of Oral and Maxillofacial Surgery, Department of Dentistry, Inha University School of Medicine) ;
  • Jung, Bum-Sang (Division of Oral and Maxillofacial Surgery, Department of Dentistry, Inha University School of Medicine) ;
  • Pae, Sang-Pill (Division of Oral and Maxillofacial Surgery, Department of Dentistry, Inha University School of Medicine) ;
  • Cho, Hyun-Woo (Division of Oral and Maxillofacial Surgery, Department of Dentistry, Inha University School of Medicine) ;
  • Seo, Ji-Hoon (Division of Oral and Maxillofacial Surgery, Department of Dentistry, Inha University School of Medicine) ;
  • Park, Seung-Hoon (Department of Oral and Maxillofacial Surgery, Catholic Kwandong University International St. Mary's Hospital)
  • Received : 2016.06.02
  • Accepted : 2016.09.09
  • Published : 2016.10.31

Abstract

We report a case of retiform hemangioendothelioma (RH) located in the infratemporal fossa and buccal area in a 13-year-old Korean boy. The tumor originated from the sphenoid bone of the infratemporal fossa area and spread into the cavernous sinus, orbital apex, and retro-nasal area with bone destruction of the pterygoid process. Tumor resection was conducted via Le Fort I osteotomy and partial maxillectomy to approach the infratemporal fossa and retro-nasal area. The diagnosis of RH was confirmed after surgery. In the presented patient, surgical excision was incomplete, and close follow-up was performed. There was no evidence of expansion or metastasis of the residual tumor in the 8 years after surgery. In cases of residual RH with low likelihood of expansion and metastasis, even though RH is an intermediate malignancy, close follow-up can be the appropriate treatment choice over additional aggressive therapy. To date, 29 papers and 48 RH cases have been reported, including this case. This case is the second reported RH case presenting as primary bone tumor and the first case originating in the oromaxillofacial area.

Keywords

References

  1. Calonje E, Fletcher CD, Wilson-Jones E, Rosai J. Retiform hemangioendothelioma. A distinctive form of low-grade angiosarcoma delineated in a series of 15 cases. Am J Surg Pathol 1994;18:115-25. https://doi.org/10.1097/00000478-199402000-00001
  2. Fukunaga M, Endo Y, Masui F, Yoshikawa T, Ishikawa E, Ushigome S. Retiform haemangioendothelioma. Virchows Arch 1996;428:301-4.
  3. Aditya GS, Santosh V, Yasha TC, Shankar SK. Epithelioid and retiform hemangioendothelioma of the skull bone--report of four cases. Indian J Pathol Microbiol 2003;46:645-9.
  4. El Darouti M, Marzouk SA, Sobhi RM, Bassiouni DA. Retiform hemangioendothelioma. Int J Dermatol 2000;39:365-8. https://doi.org/10.1046/j.1365-4362.2000.00841-1.x
  5. Tan D, Kraybill W, Cheney RT, Khoury T. Retiform hemangioendothelioma: a case report and review of the literature. J Cutan Pathol 2005;32:634-7. https://doi.org/10.1111/j.0303-6987.2005.00379.x
  6. Serel S, Serel BI, Uluc A, Heper AO, Gultan MS. Congenital retiform hemangioendothelioma. Indian J Dermatol 2007;52:160-2. https://doi.org/10.4103/0019-5154.35354
  7. O'Duffy F, Timon C, Toner M. A rare angiosarcoma: retiform haemangioendothelioma. J Laryngol Otol 2012;126:200-2. https://doi.org/10.1017/S0022215111002398
  8. Albertini AF, Brousse N, Bodemer C, Calonje E, Fraitag S. Retiform hemangioendothelioma developed on the site of an earlier cystic lymphangioma in a six-year-old girl. Am J Dermatopathol 2011;33:e84-7. https://doi.org/10.1097/DAD.0b013e31821b0a9f
  9. Zhang G, Lu Q, Yin H, Wen H, Su Y, Li D, et al. A case of retiform-hemangioendothelioma with unusual presentation and aggressive clinical features. Int J Clin Exp Pathol 2010;3:528-33.
  10. Hirsh AZ, Yan W, Wei L, Wernicke AG, Parashar B. Unresectable retiform hemangioendothelioma treated with external beam radiation therapy and chemotherapy: a case report and review of the literature. Sarcoma 2010. doi: 10.1155/2010/756246.
  11. Duke D, Dvorak A, Harris TJ, Cohen LM. Multiple retiform hemangioendotheliomas. A low-grade angiosarcoma. Am J Dermatopathol 1996;18:606-10. https://doi.org/10.1097/00000372-199612000-00010
  12. Dufau JP, Pierre C, De Saint Maur PP, Bellavoir A, Gros P. Retiform hemangioendothelioma. Ann Pathol 1997;17:47-51.
  13. Mentzel T, Stengel B, Katenkamp D. Retiform hemangioendothelioma. Clinico-pathologic case report and discussion of the group of low malignancy vascular tumors. Pathologe 1997;18:390-4. https://doi.org/10.1007/s002920050231
  14. Sanz-Trelles A, Rodrigo-Fernandez I, Ayala-Carbonero A, Contreras-Rubio F. Retiform hemangioendothelioma. A new case in a child with diffuse endovascular papillary endothelial proliferation. J Cutan Pathol 1997;24:440-4. https://doi.org/10.1111/j.1600-0560.1997.tb00820.x
  15. Schommer M, Herbst RA, Brodersen JP, Kiehl P, Katenkamp D, Kapp A, et al. Retiform hemangioendothelioma: another tumor associated with human herpesvirus type 8? J Am Acad Dermatol 2000;42:290-2. https://doi.org/10.1016/S0190-9622(00)90143-9
  16. Ulrich D, Hrynyschyn K. Fast growing multifocal retiform hemangioendothelioma: a case report. Eur J Plast Surg 2002;25:47-9. https://doi.org/10.1007/s00238-001-0337-5
  17. Coutinho MLF. Laser indications hemangiomas in children. An Acad Nac Med 2002;162:74-6.
  18. Escudero AG, Sanchez JS, Bustos GN, Serrano TG, Martin JJR, Campora RG. Retiform hemangioendothelioma: a report of two cases and literature review. Acta Dermosifiliogr 2003;94:102-6. https://doi.org/10.1016/S0001-7310(03)79234-5
  19. Botros MF, Abdo I, Foda S, Amer H, Attia N, Saad S, et al. Retiform hemangioendothelioma. Egypt Dermatol Online J 2005;1:1-4.
  20. Ioannidou D, Panayiotides J, Krasagakis K, Stefanidou M, Manios A, Tosca A. Retiform hemangioendothelioma presenting as bruiselike plaque in an adult woman. Int J Dermatol 2006;45:53-5. https://doi.org/10.1111/j.1365-4632.2004.02341.x
  21. Parsons A, Sheehan DJ, Sangueza OP. Retiform hemangioendotheliomas usually do not express D2-40 and VEGFR-3. Am J Dermatopathol 2008;30:31-3. https://doi.org/10.1097/DAD.0b013e31815ea7c5
  22. Love WE, Keiler SA, Tamburro JE, Honda K, Gosain AK, Bordeaux JS. Surgical management of congenital dermatofibrosarcoma protuberans. J Am Acad Dermatol 2009;61:1014-23. https://doi.org/10.1016/j.jaad.2009.05.028
  23. Bhutoria B, Konar A, Chakrabarti S, Das S. Retiform hemangioendothelioma with lymph node metastasis: a rare entity. Indian J Dermatol Venereol Leprol 2009;75:60-2. https://doi.org/10.4103/0378-6323.45223
  24. Emberger M, Laimer M, Steiner H, Zelger B. Retiform hemangioendothelioma: presentation of a case expressing D2-40. J Cutan Pathol 2009;36:987-90. https://doi.org/10.1111/j.1600-0560.2009.01161.x
  25. Kajo K, Machalekova K, Pauer M. Retiform hemangioendotelioma in a 8-year-old girl--case report. Cesk Patol 2009;45:72-4.
  26. Aydingöz IE, Mansur AT, Celasun B. Correspondence: retiform hemangioendothelioma presenting as a hyperhidrotic tumor. Int J Dermatol 2010;49:1076-77. https://doi.org/10.1111/j.1365-4632.2009.04282.x
  27. Choi WK, Lee SH, Oh SA, Kang DH. Retiform hemangioendothelioma on the finger. Arch Plast Surg 2012;39:80-2. https://doi.org/10.5999/aps.2012.39.1.80
  28. Findikçioglu K, Findikçioglu F, Kutlugun C, Karabagli P. Retiform hemangioendothelioma originated from capillary malformation: a rare case. Turk J Plast Surg 2012;20:12-5.
  29. Requena L, Kutzner H. Hemangioendothelioma. Semin Diagn Pathol 2013;30:29-44. https://doi.org/10.1053/j.semdp.2012.01.003
  30. Zhang M, Garvis W, Linder T, Fisch U. Update on the infratemporal fossa approaches to nasopharyngeal angiofibroma. Laryngoscope 1998;108:1717-23. https://doi.org/10.1097/00005537-199811000-00023
  31. Roche PH, Fournier HD, Laccourreye L, Mercier P. Surgical anatomy of the infratemporal fossa using the transmaxillary approach. Surg Radiol Anat 2001;23:209-13. https://doi.org/10.1007/s00276-001-0209-5

Cited by

  1. The removal of midface tumors by Le Fort I approach vol.69, pp.3, 2019, https://doi.org/10.23736/s0392-6621.19.02221-5